Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROWN R., HAZEN E. L., MASON A. Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans. Science. 1953 May 29;117(3048):609–610. doi: 10.1126/science.117.3048.609. [DOI] [PubMed] [Google Scholar]
- Childs A. J. Effect of Nystatin on Growth of Candida albicans During Antibiotic Therapy. Br Med J. 1956 Mar 24;1(4968):660–662. doi: 10.1136/bmj.1.4968.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DROUHET E. Action de la nystatine (fungicidine) in vitro et in vivo sur Candida albicans et autres champignons levuriformes. Ann Inst Pasteur (Paris) 1955 Mar;88(3):298–314. [PubMed] [Google Scholar]
- HAZEN E. L., BROWN R. Two antifungal agents produced by a soil actinomycete. Science. 1950 Oct 13;112(2911):423–423. [PubMed] [Google Scholar]
- ROBINSON R. C. Systemic moniliasis treated with mycostatin; case report. J Invest Dermatol. 1955 Apr;24(4):375–375. doi: 10.1038/jid.1955.51. [DOI] [PubMed] [Google Scholar]
- SAREWITZ A. B. Treatment of genitourinary moniliasis with orally administered nystatin. Ann Intern Med. 1955 Jun;42(6):1187–1189. doi: 10.7326/0003-4819-42-6-1187. [DOI] [PubMed] [Google Scholar]
- SLOANE M. B. A new antifungal antibiotic, mycostatin (nystatin), for the treatment of moniliasis: a preliminary report. J Invest Dermatol. 1955 Jun;24(6):569–571. doi: 10.1038/jid.1955.77. [DOI] [PubMed] [Google Scholar]